Has Hugo Vargas, MD received payments from drug or device companies?

Yes. Drug and device makers reported $38,045 in general payments to Hugo Vargas, MD across 22 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hugo Vargas, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hugo Vargas, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hugo Vargas, MD

Gastroenterology · Scottsdale, AZNPI 1730164260

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $35,875 of the $38,045 with a category attached, or 94.3%. Mallinckrodt Hospital Products Inc. accounts for 77.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $16,625 and has fallen 98.3% since, to $275 in 2025. Among gastroenterology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$38,045in general payments, 2019–2025

Across 22 payments — averaging $1729.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Mallinckrodt Hospital Products Inc.$30K
Gilead$6K
Mallinckrodt Enterprises LLC$2K
Sequana Medical US Inc.$260
Madrigal Pharmaceuticals$102
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$73
plus $15 from 1 others

$397,290in research payments, 2019–2025

Across 75 payments — averaging $5297.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Takeda Pharmaceuticals U.S.A., Inc.$251K
Grifols Therapeutics LLC$120K
Mallinckrodt Enterprises LLC$18K
Transmedics, Inc.$6K
Sequana Medical US Inc.$2K
AbbVie$500

What the payments were for

Consulting fees$35,87594%
Travel & lodging$1,4764%
Food & beverage$6942%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Mallinckrodt Hospital Products Inc.	9	$29,574
Gilead	2	$6,430
Mallinckrodt Enterprises LLC	4	$1,592
Sequana Medical US Inc.	3	$260
Madrigal Pharmaceuticals	2	$102
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$73
Grifols Shared Services North America, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

alfapump System$199

How this compares

$38,045 in reported general payments places this provider in the 90th percentile of 355 gastroenterology providers in Arizona.

See all gastroenterology providers in Arizona →

Medicare billing

Part B allowed, 2024

$45,928

Medicare patients

287

Services billed

472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tacrolimus	52	$6,921
Ursodiol	41	$6,784
Valganciclovir Hcl	25	$5,210
Fluconazole	46	$1,170
Mycophenolate Mofetil	13	$1,166
Entecavir	16	$738
Azathioprine	19	$537
Fenofibrate	13	$455
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	25	$192
Prednisone	14	$160
Carvedilol	15	$158
Pantoprazole Sodium	16	$153
Furosemide	21	$106
Spironolactone	13	$84
Methocarbamol	11	$76

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Scottsdale

Daniel MelineScottsdale$795K
David FleischerScottsdale$410K
Pankaj PasrichaScottsdale$304K
Norio FukamiScottsdale$215K
Toufic KachaamyScottsdale$210K
Christina HaScottsdale$198K
Woong KimScottsdale$138K
Adam HarrisScottsdale$127K
Anil SeetharamScottsdale$111K
Amar ThosaniScottsdale$97K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →